F Vingopoulos, M Kasetty, I Garg… - Clinical …, 2022 - researchgate.net
Background: To characterize contrast sensitivity function (CSF) in cataractous and pseudophakic eyes compared to healthy control eyes using a novel quantitative CSF test …
F Vingopoulos, M Kasetty, I Garg… - Clinical …, 2022 - dovepress.com
Background: To characterize contrast sensitivity function (CSF) in cataractous and pseudophakic eyes compared to healthy control eyes using a novel quantitative CSF test …
F Vingopoulos, M Kasetty, I Garg… - Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Background To characterize contrast sensitivity function (CSF) in cataractous and pseudophakic eyes compared to healthy control eyes using a novel quantitative CSF test …
F Vingopoulos, M Kasetty, I Garg… - Clinical …, 2022 - europepmc.org
Background To characterize contrast sensitivity function (CSF) in cataractous and pseudophakic eyes compared to healthy control eyes using a novel quantitative CSF test …
F Vingopoulos, M Kasetty, I Garg… - Clinical …, 2022 - search.proquest.com
Background: To characterize contrast sensitivity function (CSF) in cataractous and pseudophakic eyes compared to healthy control eyes using a novel quantitative CSF test …
F Vingopoulos, M Kasetty, I Garg… - Clinical …, 2022 - europepmc.org
Background To characterize contrast sensitivity function (CSF) in cataractous and pseudophakic eyes compared to healthy control eyes using a novel quantitative CSF test …